Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by ORLINSKA, U.
Right arrow Articles by GILLESPIE, M. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ORLINSKA, U.
Right arrow Articles by GILLESPIE, M. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 Oxford University Press

research-article

Acetylated Polyamines in Lungs from Rats with Monocrotaline-Induced Pneumotoxicity1

URSZULA ORLINSKA, JACK W. OLSON, SARAH ALLEN GEBB and MARK N. GILLESPIE2

Division of Pharmacology and Toxicology, University of Kentucky College of Pharmacy Lexington, Kentucky 40536-0082

Received June 27, 1988; accepted January 25, 1989

Multiple lines of evidence implicate the polyamines, putrescine, spermidine, and spermine in the lung injury and hypertensive pulmonary vascular disease produced in rats by the pyrrolizidine alkaloid monocrotaline. While increases in lung polyamine content evoked by monocrotaline can be attributed in part to induction of the two rate-limiting enzymes in de novo polyamine synthesis, ornithine decarboxylase and S-adenosylmethionine decarboxylase, little attention has been paid to the role that catabolic interconversion processes might play in lung polyamine accumulation. Accordingly, the present study evaluated dose (10–60 mg/kg) and time (0–21 days)-dependent effects of monocrotaline on lung contents of acetylated polyamines and on the activity of spemidine/spermine acetyltransferase (SAT), the enzyme affecting spermidine acetylation. A single subcutaneous injection of monocrotaline produced dose- and time-dependent increases in the lung contents of N1-acetylspermidine. Neither N1-acetylspermine nor N1-acetylputrescine could be detected in lungs from control rats or from rats treated with monocrotaline. SAT activity also was increased in monocrotaline-treated rat lungs in a dose- and tunedependent manner that was closely related to increases in the lung burden of N1-acetylspermidine. As expected, monocrotaline also caused dose- and time-dependent elevations in the lung contents of the primary polyamines, putrescine, spermidine, and spermine. Right ventricular hypertrophy, an index of sustained pulmonary hypertension, did not develop in animals treated with 10 or 20 mg/kg monocrotaline despite elevations in the lung contents of putrescine and N1-acetylspermidine and increases in the activity of SAT. In contrast,30 and 60 mg/kg monocrotaline provoked right ventricular hypertrophy accompanied by elevations in the primary polyaming N1-acetylspermidine, and SAT activity. These observations indicate that monocrotaline-induced pneumotoxicity, characterized by development of sustained pulmonary hypertension, is associated with increased activity of SAT and accumulation of N1-acetylspermidine as well as the primary polyamines. This association suggests that polyamine interconversion pathways may be important in development of monocrotaline-induced pneumotoxicity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.